Globally, health authorities increasingly expect person-centred care, yet its meaning and implementation remain misunderstood. To address this, innovative strategies are needed to support healthcare professionals in embedding person-centred practices. This symposium presents a set of eight Person-Centred Nursing and Midwifery Key Performance Indicators (KPIs), and a validated measurement framework tested internationally across diverse settings. These KPIs have been integrated into the iMPAKT App, which collects, manages, and analyses patient experience data. The App also helps nurses and midwives translate insights from the data into meaningful practice improvements. This symposium will demonstrate how the KPIs and iMPAKT App enhance the quality and safety of person-centred nursing and midwifery care. Three interlinked presentations will highlight this International Research Programme focusing on outcomes of the work, how the App is used in practice through an organisational case study and the challenges in ensuring sustainability of iMPAKT. Presentation 1 Wilson V & McCance T This presentation will provide an overview of iMPAKT and the implementation and evaluation studies that have taken place globally. We will showcase the outcome of the iMPAKT programme in terms of research, development and practice. Presentation 2 Tuqiri K, Wilson V & Mulcahy M Prince of Wales Hospital in Sydney is the first to implement the iMPAKT App organisation-wide, across 29 clinical units—including inpatient, ambulatory, community, and virtual services. This presentation will highlight the critical enablers of success: strong leadership at all levels, dedicated iMPAKT champions, targeted facilitation for nursing staff, celebrating progress, and a robust governance structure. Presentation 3 McCance T, Wilson V & Muldrew D This presentation will chart the journey of advancing the research program into the innovation domain, ensuring the technology stays current and widely accessible. The associated challenges for sustainability and scalability globally will be explored, alongside the benefits for commercialisation.